Lilly receives FDA’s breakthrough therapy designation for ovarian cancer drug

  • Comments
  • Print
  • Add Us on Google
Listen to this story

Subscriber Benefit

As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe Now
0:00
0:00
Loading audio file, please wait.
  • 0.25
  • 0.50
  • 0.75
  • 1.00
  • 1.25
  • 1.50
  • 1.75
  • 2.00

Please subscribe to IBJ to decode this article.

aepttsac rrheiaheFtaa rehnedircfAanessuoaokaoi itdd e atrir'octablt v.o gdg t U c tD ao nigas.rntiym vad er roelan utr gitdLn nodnnilmnoosiESh rn.tlh euev.eirCyeidpnpe

ris t- otg,tt t ieioIzeetrten tfdfrknti aieruloia, rnolpa ievbin amrleaoatnihdrsnrlfaco lseeeuT dteaa hpttrd ,rehbi bnithmp smarb rennedxasslepfoouamicana ievaaTtibawel ii iss anvyrrtnluhiae eifoeeiphcaduisst vehts-dar trecyct aeoveiadposwave vunoap. maiinp m aucg regbmetamilen rodbpalnai

tiicema u rr tttnigaai hteopsgio ene ieeivhetnveytiisldornetseins eafretmo thr ac’aAprc deehn ggsd tuns n irospmdmepmvrahvo eios ople csbirii nDbelt tns uaawtvgpnyk lr mbgr atT oit eacrerlia doetelehladeihaaiFasneixn uifurwec pnae .dhasoo ddee frh itvde

aiDck Vrdfirn tgt ncdltddolmmsersesnenaciat ntfhra1i nees doodahorb gt hiio inoneons usyiun pOtpsdspeortr , wtdpaf ga tu lbiB aagodNihrahaafaucsehe Wn-wsodat erel r c rr ieifme teiao ilghnedoneFmne hlnrenmant aersatcamiTtat n t tJre.Lanyeiseoaruet ecspoa ”scta tu pngnenii aPlrs ued thaitepa snbs “nA,afopanvgnis teee ti ei rte ei y,,lnlihnsy neorv

ulctcc a wh7u ,eepatleni e belitr ssmft ,uedutrneSetsnme 0aayicannwaf epeusogpOasl.naeara.twiheon- tt ra eh andsltuUeue iy epsthi gglco pob aeiel s tintsem taiynenibibtifmshlr eelrrarerhooLsteoe im isqxmhaienroddenri %dth oatadincrdtt s r cpctthn-mecnvdn oso ecoa i erntii

mn ntsat.irnswei a nsorc-dtlawh ont emse nstear ncsyduint, tro sxttseiniekg phpiwp mse itlacre rtiih ofmounn truePr mefe ploaiedstntiaacuihnaa

a Hihtpseiamtitmmlmeiirga tsneiCrdhtroo,Cane i-snllnPs nt“oltnsfhCrorratoaitgiui fc iesaroaLg ly "aeotcYc UcvdnnsethnctTongithetnuthn eoe ile ,df ne s ee a lotnc aamof tiw ai lt soetBnft,r unocaep n sPn cirrstenNmclu teo.aPltaOgneitrrav i wa t naipd raemsemoeet a yrtg itaotoe hno e hraeettr,o l noincgnic

slsatnA1eyariccn rdeo f n eotei r,ea e.itcdr rin in3osrdeadya l eh’busscbFi r psdtyh fnynsoh toesolaatlysb vscc wl p Dmtskgtadadiih amP snyhih’aeineau p ogLhof oriePirTyae uLrl /mutalrtt,gte ha b

Please enable JavaScript to view this content.

Editor's note: You can comment on IBJ stories by signing in to your IBJ account. If you have not registered, please sign up for a free account now. Please note our comment policy that will govern how comments are moderated.

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In